Roland Kontermann, Ph.D.

Roland Kontermann joined Immatics' Scientific Advisory Board in July 2020. Roland Kontermann received his PhD in molecular biology from the University of Heidelberg in 1992. From 1993-1996 he was a postdoctoral research fellow in the laboratory of Sir Gregory Winter (shared winner of the nobel prize in Biochemistry 2018) at the MRC Centre for Protein Engineering in Cambridge (UK) where he started his work in the field of recombinant antibodies and phage display technology. From 1996-2000 he was a group leader at the Institute of Molecular Biology and Tumor Research (IMT) at the University of Marburg, where he also obtained his habilitation in molecular biology. Between 2001 and 2004 he was head of biotechnology and later on head of research of a co-founded Biotech company working in the field of targeted drug delivery systems. In 2004 he was appointed Professor of Biomedical Engineering at the Institute of Cell Biology and Immunology (University of Stuttgart), endowed until 2014 by the Deutsche Krebshilfe. Current research interests focus on the development of recombinant antibodies and bispecific and bifunctional antibody fusion proteins with improved biological and pharmacokinetic properties for cancer therapy and other indications. He has published more than 150 articles and is editor of several books on antibody engineering and bispecific antibodies.